Lahong Zhang
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Analysis of the Clinical Application Value of Immune Function Markers and Cytokines in the Recurrent Aphthous Ulcer.
Journal: Clinical and experimental dental research
Published: August 20, 2025
5'-tiRNA-Lys maintains intestinal epithelial homeostasis by EWSR1-dependent suppression of miR-125a and autophagy activation.
Journal: Acta biochimica et biophysica Sinica
Published: June 21, 2025
Exploration of plasma exosomal miR-122-5p and its related targets KNG1 and C3 in the diagnosis of drug-resistant tuberculosis.
Journal: Scientific reports
Published: March 11, 2025
Identification of estrogen response-associated STRA6+ granulosa cells within high-grade serous ovarian carcinoma by single-cell sequencing.
Journal: Heliyon
Published: December 13, 2023
Combined Detection of IFN-γ and Lymphocyte Subsets with Activation Indicators in the Clinical Application of Mycobacterium Tuberculosis Infection at Different Times.
Journal: Current microbiology
Published: August 25, 2022
A Systematic Analysis Reveals the Prognostic and Immunological Role of Reptin/RUVBL2 in Human Tumors.
Journal: Frontiers in genetics
Published: April 02, 2022
Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging.
Journal: Journal of ovarian research
Published: September 09, 2021
Rapid diagnosis of pulmonary tuberculosis and detection of drug resistance by combined simultaneous amplification testing and reverse dot blot.
Journal: Journal of clinical pathology
Published: August 03, 2017
Comparison of the performance in detection of HPV infections between the high-risk HPV genotyping real time PCR and the PCR-reverse dot blot assays.
Journal: Journal of medical virology
Published: May 19, 2017
MicroRNA-205 promotes cell invasion by repressing TCF21 in human ovarian cancer.
Journal: Journal of ovarian research
Published: March 02, 2017
miR-125b inhibited epithelial-mesenchymal transition of triple-negative breast cancer by targeting MAP2K7.
Journal: OncoTargets and therapy
Published: May 27, 2016
Last Updated: 09/26/2026